The 2nd Peptide-Based Therapeutics Summit will return to Boston in April 2025, bringing together over 80 experts in peptide computational science, medicinal chemistry, and formulation to discuss the latest advancements shaping the next generation of peptide-based therapies—from early-stage discovery to clinical application.

Download the three-day program here: https://ter.li/rrvg1v

This year’s summit will highlight groundbreaking innovations in peptide therapeutics, including:

• Peptide 3D structure prediction, hit generation, and lead optimization, featuring insights from Chugai Pharmaceutical, PeptiDream, and Insamo
• Strategies for optimizing oral bioavailability and cell permeability in peptide design, with contributions from Orbis Medicines and Ohio State University
• Peptide formulation techniques for optimal target binding, solubility, stability, and safety, with expertise from Halozyme and Oramed Pharmaceuticals

Join us to shape your peptide drug discovery and development strategy for 2025 and discover the therapeutic potential of cutting-edge peptide-based medicines.